Celebrate 2018 Medical Laboratory Professionals Week With MiraVista
April 22-28 is 2018 Medical Laboratory Professionals Week, which is celebrated each year to increase public understanding of and appreciation for laboratory personnel. The theme for this important industry campaign has been “Laboratory Professionals Get Results” since 2010. MiraVista Celebrates 2018…
READ MORE →
MiraVista Receives $630,000 in Federal & State Research Grants
National Institutes of Health (NIH) and the State of Indiana Awarded MiraVista Diagnostics More Than $630,000 in Grant Funding to Support Fungal Disease Research to Develop a New Rapid Detection Test for Coccidioidomycosis MiraVista Diagnostics, LLC (MiraVista), a developer of…
READ MORE →
MiraVista is Participating in the 62nd Annual Cocci Study Group Meeting in Flagstaff, Arizona
MiraVista Diagnostics is participating in the 62nd Annual Cocci Study Group Meeting on April 13-14 in Flagstaff, Arizona. Representatives from the company will be available to discuss MiraVista’s menu of diagnostic tests for serious fungal infections. To learn more about…
READ MORE →
Inside Indiana Business Life Sciences Features MiraVista Diagnostics
Inside Indiana Business recently featured Indianapolis headquartered MiraVista Diagnostics in its Life Sciences Indiana publication. During the interview, Dr. Lawrence Joseph Wheat shared exciting news about the company’s research initiatives and expansion plans. Read the article below or link directly to…
READ MORE →
MiraVista is Attending the 2018 SCACM Spring Meeting in French Lick, Indiana
MiraVista Diagnostics is attending the South Central Association for Clinical Microbiology’s 2018 SCACM Spring Meeting in French Lick, Indiana on March 7-10, 2018. Representatives from the company’s clinical laboratory will be available to discuss MiraVista’s menu of diagnostic tests for…
READ MORE →
NIH Approved Institutional Biosafety Committee (IBC) First Meeting Scheduled for January 29
In compliance with the National Institutes of Health Office of Science Policy (NIH OSP), MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC) to review, approve and confirm that the company’s research involving recombinant/synthetic DNA complies with NIH guidelines….
READ MORE →
NEW: MVista® Histoplasma Antibody IgG IgM EIA
Improve Diagnosis of Acute Pulmonary Histoplasmosis by Combining Antigen & Antibody Testing Review the technical specifications for the NEW MVista® Histoplasma Antibody IgG IgM EIA>> CLINICAL BACKGROUND Acute pulmonary histoplasmosis (APH) can be severe, especially following heavy exposure and is…
READ MORE →
Experience the Advantage
MiraVista Diagnostics is the Authority on Serious Fungal Infections
Since MiraVista Diagnostics was founded in 2002 by the renowned infectious disease scientist, Lawrence Joseph Wheat, MD, the company has been the leading authority on serious fungal infections. Today, MiraVista is a CAP + CLIA certified clinical laboratory that processes over 100,000 fungal diagnostic tests every year. MiraVista is respected for its scientific contributions and selected for its:
- Menu of Fungal Infection Tests
- Onsite Clinical Reference Lab
- Same Day Testing
- Prompt + Professional Response
- Fast Turnaround Time
- Experienced ID Specialists
Let us earn your trust and your business. Order fungal diagnostic tests today to experience the MiraVista advantage.
